Inhibition of p38 MAP kinase as a therapeutic strategy

Immunopharmacology - Tập 47 - Trang 185-201 - 2000
John C Lee1, Sanjay Kumar1, Don E Griswold1, David C Underwood1, Bartholomew J Votta1, Jerry L Adams1
1SmithKline Beecham Pharmaceuticals, 709 Swedeland Road, King of Prussia, PA 19406 USA

Tài liệu tham khảo

Adams, 1998, Pyrimidinylimidazole inhibitors of CSBP/p38 kinase demonstrating decreased inhibition of hepatic cytochrome P450 enzymes, Bioorg. Med. Chem. Lett., 8, 3111, 10.1016/S0960-894X(98)00549-6 Badger, 1996, Pharmacological profile of SB 203580, a selective inhibitor of CSBP/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function, J. Pharmacol. Exp. Ther., 279, 1453 Badger, 1998, SB 203580 inhibits p38 mitogen-activated protein kinase, nitric oxide production, and inducible nitric oxide synthase in bovine cartilage-derived chondrocytes, J. Immunol., 161, 467, 10.4049/jimmunol.161.1.467 Bagrodia, 1995, Cdc42 and PAK-mediated signaling leads to Jun kinase and p38 mitogen-activated protein kinase activation, J. Biol. Chem., 270, 27995, 10.1074/jbc.270.47.27995 Barnes, 1998, Inflammatory mediators of asthma: an update, Pharmacol. Rev., 50, 515 Ben-Levy, 1998, Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2, Curr. Biol., 8, 1049, 10.1016/S0960-9822(98)70442-7 Benna, 1997, Phosphorylation of the respiratory burst oxidase subunit p67(phox) during human neutrophil activation. Regulation by protein kinase C-dependent and independent pathways, J. Biol. Chem., 272, 17204, 10.1074/jbc.272.27.17204 Beyaert, 1996, The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor, EMBO Journal, 15, 1914, 10.1002/j.1460-2075.1996.tb00542.x Bhat, 1998, Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures, J. Neurosci., 18, 1633, 10.1523/JNEUROSCI.18-05-01633.1998 Boehm, 2000, New inhibitors of p38 kinase, Exp. Opin. Ther. Pat., 10, 25, 10.1517/13543776.10.1.25 Boemer, 1995, Kinetic mechanisms of the forward and reverse pp60c-src tyrosine kinase reactions, Biochemistry, 34, 16419, 10.1021/bi00050a024 Borsch-Haubold, 1997, Phosphorylation and activation of cytosolic phospholipase A2 by 38-kDa mitogen-activated protein kinase in collagen-stimulated human platelets, Eur. J. Biochem., 245, 751, 10.1111/j.1432-1033.1997.t01-1-00751.x Bracke, 1998, Analysis of signal transduction pathways regulating cytokine-mediated Fc receptor activation on human eosinophils, J. Immunol., 161, 6768, 10.4049/jimmunol.161.12.6768 Caput, 1986, Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators, Proc. Natl. Acad. Sci. U. S. A., 83, 1670, 10.1073/pnas.83.6.1670 Clifton, 1996, Comparison of the substrate specificity of MAPKAP kinase-2 and MAPKAP kinase-3 and their activation by cytokines and cellular stress, FEBS Lett., 392, 124, 10.1016/0014-5793(96)00816-2 Cobb, 1995, How MAP kinases are regulated, J. Biol. Chem., 270, 14843, 10.1074/jbc.270.25.14843 Cohen, 1997, The search for physiological substrates of MAP and SAP kinases in mammalian cells, Trends Cell Biol., 7, 353, 10.1016/S0962-8924(97)01105-7 Cook, 1982, Adenosine cyclic 3′–5′-monophosphate dependent protein kinase: kinetic mechanism of the bovine skeletal muscle catalytic subunit, Biochemistry, 21, 5794, 10.1021/bi00266a011 Craxton, 1998, p38 MAPK is required for CD40-induced gene expression and proliferation in B lymphocytes, J. Immunol., 161, 3225, 10.4049/jimmunol.161.7.3225 Cuenda, 1995, SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1, FEBS Lett., 364, 229, 10.1016/0014-5793(95)00357-F Cuenda, 1997, Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6); comparison of the specificities of SAPK3 and SAPK2 (RK/p38), EMBO J., 16, 295, 10.1093/emboj/16.2.295 Cuenda, 1997, Activation of the novel MAP kinase homologue SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6), Biochem. Soc. Trans., 25, S569, 10.1042/bst025s569 Deak, 1998, Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB, EMBO J., 17, 4426, 10.1093/emboj/17.15.4426 de Laszlo, 1998, Pyrroles and other heterocycles as inhibitors of p38 kinase, Bioorg. Med. Chem. Lett., 8, 2689, 10.1016/S0960-894X(98)00495-8 Derijard, 1994, JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain, Cell, 76, 1025, 10.1016/0092-8674(94)90380-8 Derijard, 1995, Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms, Science, 267, 682, 10.1126/science.7839144 Doza, 1995, Activation of the MAP kinase homologue RK requires the phosphorylation of Thr-180 and Tyr-182 and both residues are phosphorylated in chemically stressed KB cells, FEBS Lett., 364, 223, 10.1016/0014-5793(95)00346-B Enslen, 1998, Selective activation of p38 mitogen-activated protein (MAP) kinase: isoforms by the kinase kinases MKK3 and MKK6, J. Biol. Chem., 273, 1741, 10.1074/jbc.273.3.1741 Eyers, 1998, Conversion of SB 203580-insensitive MAP kinase family members to drug-sensitive forms by a single amino-acid substitution, Chem. Biol., 5, 321, 10.1016/S1074-5521(98)90170-3 Foltz, 1998, Human mitogen-activated protein kinase kinase 7 (MKK7) is a highly conserved c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) activated by environmental stresses and physiological stimuli, J. Biol. Chem., 273, 9344, 10.1074/jbc.273.15.9344 Fox, 1998, A single amino acid makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase, Protein Sci., 7, 2249, 10.1002/pro.5560071102 Frantz, 1998, The activation state of p38 mitogen-activated protein kinase determines the efficiency of ATP competition of pyridinylimidazole inhibitor binding, Biochemistry, 37, 13846, 10.1021/bi980832y Freed, 1995, Models and mechanism of exercise-induced asthma, J. Eur. Respir., 8, 1765, 10.1183/09031936.95.08101770 Fukunaga, 1997, MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates, EMBO J., 16, 1921, 10.1093/emboj/16.8.1921 Gallagher, 1995, 2,4,5-Triarylimidazole inhibitors of IL-1 biosynthesis, Bioorg. Med. Chem. Lett., 5, 1171, 10.1016/0960-894X(95)00189-Z Gallagher, 1997, Regulation of stress-induced cytokine production by pyridinylimidazoles: inhibition of CSBP kinase, Bioorg. Med. Chem., 5, 49, 10.1016/S0968-0896(96)00212-X Goedert, 1997, Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6) — comparison of its substrate specificity with that of other SAP kinases, EMBO J., 16, 3563, 10.1093/emboj/16.12.3563 Goedert, 1997, Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases, FEBS Lett., 409, 57, 10.1016/S0014-5793(97)00483-3 Guay, 1997, Regulation of actin filament dynamics by p38 map kinase-mediated phosphorylation of heat shock protein 27, J. Cell Sci., 110, 357, 10.1242/jcs.110.3.357 Gum, 1998, Acquisition of sensitivity of stress-activated protein kinases to the p38 inhibitor, SB 203580, by alteration of one or more amino acids within the ATP binding pocket, J. Biol. Chem., 273, 15605, 10.1074/jbc.273.25.15605 Hagmeyer, 1993, Adenovirus E1A negatively and positively modulates transcription of AP-1 dependent genes by dimer-specific regulation of the DNA binding and transactivation activities of Jun, EMBO J., 12, 3559, 10.1002/j.1460-2075.1993.tb06030.x Hale, 1999, Differential expression and activation of p38 mitogen-activated protein kinase alpha, beta, gamma, and delta in inflammatory cell lineages, J. Immunol., 162, 4246, 10.4049/jimmunol.162.7.4246 Han, 1991, Interactive effects of the tumor necrosis factor promoter and 3′-untranslated regions, J. Immunol., 146, 1843, 10.4049/jimmunol.146.6.1843 Han, 1994, A MAP kinase targeted by endotoxin in mammalian cells, Science, 265, 808, 10.1126/science.7914033 Han, 1996, Characterization of the structure and function of a novel MAP kinase kinase (MKK6), J. Biol. Chem., 271, 2886, 10.1074/jbc.271.6.2886 Han, 1997, Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation, Nature, 386, 296, 10.1038/386296a0 Hannigan, 1998, The role of p38 MAP kinase in TGF-beta-induced signal transduction in human neutrophils, Biochem. Biophys. Res. Commun., 246, 55, 10.1006/bbrc.1998.8570 Hasegawa, 1999, Stress-activated protein kinase-3 interacts with the PDZ domain of alpha1-syntrophin. A mechanism for specific substrate recognition, J. Biol. Chem., 274, 12626, 10.1074/jbc.274.18.12626 Hashimoto, 1999, Hyperosmolarity-induced interleukin-8 expression in human bronchial epithelial cells through p38 mitogen-activated protein kinase, Am. J. Respir. Crit. Care Med., 159, 634, 10.1164/ajrccm.159.2.9712090 Holland, 1999, Protein modification: docking sites for kinases, Curr. Biol., 9, 329, 10.1016/S0960-9822(99)80205-X Huang, 1997, LSP1 is the major substrate for mitogen-activated protein kinase-activated protein kinase 2 in human neutrophils, J. Biol. Chem., 272, 17, 10.1074/jbc.272.1.17 Huang, 1997, Apoptosis signaling pathway in T cells is composed of ICE/Ced-3 family proteases and MAP kinase kinase 6b, Immunity, 6, 739, 10.1016/S1074-7613(00)80449-5 Ichijo, 1997, Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways, Science, 275, 90, 10.1126/science.275.5296.90 Jackson, 1998, Pharmacological effects of SB 220025, a selective inhibitor of p38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models, J. Pharmacol. Exp. Ther., 284, 687 Janknecht, 1996, Regulation of the c-fos promoter by the ternary complex factor Sap-1a and its coactivator CBP, Oncogene, 12, 1961 Janknecht, 1996, MAP kinase-dependent transcriptional coactivation by Elk-1 and its cofactor CBP, Biochem. Biophys. Res. Commun., 228, 831, 10.1006/bbrc.1996.1740 Janknecht, 1997, Convergence of MAP kinase pathways on the ternary complex factor Sap-1a, EMBO J., 16, 1620, 10.1093/emboj/16.7.1620 Jiang, 1996, Characterization of the structure and function of a new mitogen-activated protein kinase (p38beta), J. Biol. Chem., 271, 17920, 10.1074/jbc.271.30.17920 Jiang, 1997, Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinases, p38delta, J. Biol. Chem., 272, 30122, 10.1074/jbc.272.48.30122 Kato, 1997, BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C, EMBO J., 16, 7054, 10.1093/emboj/16.23.7054 Kontoyiannis, 1999, Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies, Immunity, 10, 387, 10.1016/S1074-7613(00)80038-2 Kotyarov, 1999, MAPKAP kinase 2 is essential for LPS-induced TNF-α biosynthesis, Nat. Cell Biol., 1, 94, 10.1038/10061 Kramer, 1995, Thrombin induces activation of p38 MAP kinase in human platelets, J. Biol. Chem., 270, 27395, 10.1074/jbc.270.46.27395 Kultz, 1998, Hyperosmolality causes growth arrest of murine kidney cells. Induction of GADD45 and GADD153 by osmosensing via stress-activated protein kinase 2, J. Biol. Chem., 273, 13645, 10.1074/jbc.273.22.13645 Kumar, 1997, Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles, Biochem. Biophys. Res. Commun., 235, 533, 10.1006/bbrc.1997.6849 Kumar, 1999, Pyridinylimidazole compound SB 203580 inhibits the activity but not the activation of p38 mitogen-activated protein kinase, Biochem. Biophys. Res. Commun., 263, 825, 10.1006/bbrc.1999.1454 Landry, 1995, Modulation of actin dynamics during stress and physiological stimulation by a signaling pathway involving p38 MAP kinase and heat-shock protein 27, Biochem. Cell Biol., 73, 703, 10.1139/o95-078 Lee, 1996, Role of CSB/p38/RK stress response kinase in LPS and cytokine signaling mechanisms, J. Leukocyte Biol., 59, 152, 10.1002/jlb.59.2.152 Lee, 1993, Bicyclic imidazoles as a novel class of cytokine biosynthesis inhibitors, Ann. N. Y. Acad. Sci., 696, 149, 10.1111/j.1749-6632.1993.tb17149.x Lee, 1988, Inhibition of monocyte IL-1 production by the anti-inflammatory compound SK&F 86002, Int. J. Immunopharmacol., 10, 835, 10.1016/0192-0561(88)90007-0 Lee, 1999, p38 mitogen-activated protein kinase inhibitors — mechanisms and therapeutic potentials, Pharmacol. Ther., 82, 389, 10.1016/S0163-7258(99)00008-X Lee, 1994, A protein kinase involved in the regulation of inflammatory cytokine biosynthesis, Nature, 372, 739, 10.1038/372739a0 Li, 1996, The primary structure of p38 gamma: a new member of p38 group of MAP kinases, Biochem. Biophys. Res. Commun., 228, 334, 10.1006/bbrc.1996.1662 Lisnock, 1998, Molecular basis for p38 kinase inhibitor specificity, Biochemistry, 37, 16573, 10.1021/bi981591x LoGrasso, 1997, Kinetic mechanism for p38 MAP kinase, Biochemistry, 36, 10422, 10.1021/bi9706778 Lu, 1999, Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice, EMBO J., 18, 1845, 10.1093/emboj/18.7.1845 MacNee, W., 1994. Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease, state-of-the-art: Parts 1 and 2. Am. J. Respir. Crit. Care Med. 150, 833–852 and 1158–1168. Marshall, 1998, Inhibitors of the p38 mitogen-activated kinase modulate IL-4 induction of low affinity IgE receptor (CD23) in human monocytes, J. Immunol., 161, 6005, 10.4049/jimmunol.161.11.6005 Martin-Villalba, 1998, Rapid and long-lasting suppression of the ATF-2 transcription factor is a common response to neuronal injury, Brain Res. Mol. Brain Res., 62, 158, 10.1016/S0169-328X(98)00239-3 Matsuda, 1998, T lymphocyte activation signals for interleukin-2 production involve activation of MKK6-p38 and MKK7-SAPK/JNK signaling pathways sensitive to cyclosporin A, J. Biol. Chem., 273, 12378, 10.1074/jbc.273.20.12378 Matsumoto, 1998, Proinflammatory cytokine-induced and chemical mediator-induced IL-8 expression in human bronchial epithelial cells through p38 mitogen-activated protein kinase-dependent pathway, J. Allergy Clin. Immunol., 101, 825, 10.1016/S0091-6749(98)70311-2 McDonnell, 1995, Localization of the human stress responsive MAP kinase-like CSAIDs binding protein (CSBP) gene to chromosome 6q21.3/21.2, Genomics, 29, 301, 10.1006/geno.1995.1252 McLaughlin, 1996, Identification of mitogen-activated protein (MAP) kinase-activated protein kinase-3, a novel substrate of CSBP p38 MAP kinase, J. Biol. Chem., 271, 8488, 10.1074/jbc.271.14.8488 Mertens, 1996, SAP kinase-3, a new member of the family of mammalian stress-activated protein kinases, FEBS Lett., 383, 273, 10.1016/0014-5793(96)00255-4 Morley, 1997, FEBS Lett., 418, 327, 10.1016/S0014-5793(97)01405-1 Morley, 1997, Involvement of stress-activated protein kinase and p38/RK mitogen-activated protein kinase signaling pathways in the enhanced phosphorylation of initiation factor 4E in NIH 3T3 cells, J. Biol. Chem., 272, 17887, 10.1074/jbc.272.28.17887 New, 1998, PRAK, a novel protein kinase regulated by the p38 MAP kinase, EMBO J., 17, 3372, 10.1093/emboj/17.12.3372 Ni, 1998, MAPKAPK5, a novel mitogen-activated protein kinase (MAPK)-activated protein kinase, is a substrate of the extracellular-regulated kinase (ERK) and p38 kinase, Biochem. Biophys. Res. Commun., 243, 92, 10.1006/bbrc.1998.8135 Nick, 1996, Activation of a p38 mitogen-activated protein kinase in human neutrophils by lipopolysaccharide, J. Immunol., 156, 4867, 10.4049/jimmunol.156.12.4867 Pandey, 1999, Activation of p38 mitogen-activated protein kinase by PYK2/related adhesion focal tyrosine kinase-dependent mechanism, J. Biol. Chem., 274, 10140, 10.1074/jbc.274.15.10140 Parker, 1998, Identification of stathmin as a novel substrate for p38δ, Biochem. Biophys. Res. Commun., 249, 791, 10.1006/bbrc.1998.9250 Pierrat, 1998, RSK-B, a novel ribosomal S6 kinase family member, is a CREB kinase under dominant control of p38alpha mitogen-activated protein kinase (p38alphaMAPK), J. Biol. Chem., 273, 29661, 10.1074/jbc.273.45.29661 Posner, 1992, Kinetic model of the epidermal growth factor (EGF) receptor tyrosine kinase and a possible mechanism of its activation by EGF, J. Biol. Chem., 267, 20638, 10.1016/S0021-9258(19)36734-1 Preville, 1998, Analysis of the role of Hsp25 phosphorylation reveals the importance of the oligomerization state of this small heat shock protein in its protective function against TNFalpha- and hydrogen peroxide-induced cell death, J. Cell. Biochem., 69, 436, 10.1002/(SICI)1097-4644(19980615)69:4<436::AID-JCB5>3.0.CO;2-O Preville, 1998, Phosphorylation is not essential for protection of L929 cells by Hsp25 against H2O2-mediated disruption actin cytoskeleton, a protection which appears related to the redox change mediated by Hsp25, Cell Stress Chaperones, 3, 177, 10.1379/1466-1268(1998)003<0177:PINEFP>2.3.CO;2 Price, 1996, The p38 and ERK MAP kinase pathways cooperate to activate ternary complex factors and c-fos transcription in response to UV light, EMBO J., 15, 6552, 10.1002/j.1460-2075.1996.tb01046.x Raingeaud, 1995, Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine, J. Biol. Chem., 270, 7420, 10.1074/jbc.270.13.7420 Raingeaud, 1996, MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway, Mol. Cell Biol., 16, 1247, 10.1128/MCB.16.3.1247 Rincon, 1998, Interferon-gamma expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway, EMBO J., 17, 2817, 10.1093/emboj/17.10.2817 Rouse, 1994, A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins, Cell, 78, 1027, 10.1016/0092-8674(94)90277-1 Salituro, 1999, Inhibitors of p38 MAP kinase: therapeutic intervention in cytokine-mediated diseases, Curr. Med. Chem., 6, 807, 10.2174/092986730609220401150415 Sato, 1999, J. Immunol., 162, 3865, 10.4049/jimmunol.162.7.3865 Scott, 1998, Hypoxic stimulation of the stress-activated protein kinases in pulmonary artery fibroblasts, Am. J. Respir. Crit. Care Med., 158, 958, 10.1164/ajrccm.158.3.9712130 Sen, 1996, Intrathymic signals in thymocytes are mediated by p38 mitogen-activated protein kinase, J. Immunol., 156, 4535, 10.4049/jimmunol.156.12.4535 Shaw, 1986, A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation, Cell, 46, 659, 10.1016/0092-8674(86)90341-7 Shibuya, 1996, TAB1: an activator of the TAK1 MAPKKK in TGF-β signal transduction, Science, 272, 1179, 10.1126/science.272.5265.1179 Sithanandam, 1996, 3pK, a new mitogen-activated protein kinase-activated protein kinase located in the small cell lung cancer tumor suppressor gene, Mol. Cell Biol., 16, 868, 10.1128/MCB.16.3.868 Smith, 1999, Identification of an extracellular signal-regulated kinase (ERK) docking site in ribosomal S6 kinase, a sequence critical for activation by ERK in vivo, J. Biol. Chem., 274, 2893, 10.1074/jbc.274.5.2893 Stein, 1997, p38-2, a novel mitogen-activated protein kinase with distinct properties, J. Biol. Chem., 272, 19509, 10.1074/jbc.272.31.19509 Stokoe, 1992, Identification of MAPKAP kinase 2 as a major enzyme responsible for the phosphorylation of the small mammalian heat shock proteins, FEBS Lett., 313, 307, 10.1016/0014-5793(92)81216-9 Sutherland, 1993, Phosphorylation and activation of human tyrosine hydroxylase in vitro by mitogen-activated protein (MAP) kinase and MAP-kinase-activated kinases 1 and 2, Eur. J. Biochem., 217, 715, 10.1111/j.1432-1033.1993.tb18297.x Takekawa, 1997, A human homolog of the yeast Ssk2/Ssk22 MAP kinase kinase kinases, MTK1, mediates stress-induced activation of the p38 and JNK pathways, EMBO J., 16, 4973, 10.1093/emboj/16.16.4973 Takekawa, 1998, A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK, Cell, 95, 521, 10.1016/S0092-8674(00)81619-0 Tamura, 1998, p38 mitogen-activated protein kinase inhibition attenuates intercellular adhesion molecule-1 up-regulation on human pulmonary microvascular endothelial cells, Surgery, 124, 403, 10.1016/S0039-6060(98)70147-3 Tan, 1996, FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2, EMBO J., 15, 4629, 10.1002/j.1460-2075.1996.tb00840.x Thuerauf, 1998, p38 Mitogen-activated protein kinase mediates the transcriptional induction of the atrial natriuretic factor gene through a serum response element. A potential role for the transcription factor ATF6, J. Biol. Chem., 273, 20636, 10.1074/jbc.273.32.20636 Tong, 1997, A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket, Nat. Struct. Biol., 4, 311, 10.1038/nsb0497-311 Tournier, 1999, The MKK7 gene encodes a group of c-Jun NH2-terminal kinase kinases, Mol. Cell Biol., 19, 1569, 10.1128/MCB.19.2.1569 van Dam, 1995, ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents, EMBO J., 14, 1798, 10.1002/j.1460-2075.1995.tb07168.x Wang, 1996, Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP, Science, 272, 1347, 10.1126/science.272.5266.1347 Wang, 1997, Molecular cloning and characterization of a novel p38 mitogen-activated protein kinase, J. Biol. Chem., 272, 23668, 10.1074/jbc.272.38.23668 Wang, 1997, The structure of mitogen activated protein kinase p38 at 2.1 A resolution, Proc. Natl. Acad. Sci., 94, 2327, 10.1073/pnas.94.6.2327 Wang, 1998, Structural basis of inhibitor selectivity in MAP kinases, Structure, 6, 1117, 10.1016/S0969-2126(98)00113-0 Wang, 1998, The phosphorylation of eukaryotic initiation factor eIF4E in response to phorbol esters, cell stresses, and cytokines is mediated by distinct MAP kinase pathways, J. Biol. Chem., 273, 9373, 10.1074/jbc.273.16.9373 Ward, 1997, A p38 MAP kinase inhibitor SB 203580 inhibits CD28-dependent T cell proliferation and IL-2 production, Biochem. Soc. Trans., 25, 304S, 10.1042/bst025304s Waterman, 1996, Tumor necrosis factor-alpha-induced phosphorylation and activation of cytosolic phospholipase A2 are abrogated by an inhibitor of the cascade in human neutrophils, Biochem. J., 319, 17, 10.1042/bj3190017 Waskiewicz, 1999, Phosphorylation of the cap-binding protein eukaryotic translation initiation factor 4E by protein kinase Mnk1 in vivo, Mol. Cell Biol., 19, 1871, 10.1128/MCB.19.3.1871 Wilson, 1996, Crystal structure of p38 mitogen-activated protein kinase, J. Biol. Chem., 271, 27696, 10.1074/jbc.271.44.27696 Wilson, 1997, The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase, Chem. Biol., 4, 423, 10.1016/S1074-5521(97)90194-0 Winzen, 1999, The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism, EMBO J., 18, 4969, 10.1093/emboj/18.18.4969 Yao, 1997, Activation of stress-activated protein kinases/c-Jun N-terminal protein kinases (SAPKs/JNKs) by a novel mitogen-activated protein kinase kinase, J. Biol. Chem., 272, 32378, 10.1074/jbc.272.51.32378 Young, 1997, Pyridinyl imidazole inhibitors of p38 MAP kinase bind in the ATP site, J. Biol. Chem., 272, 12116, 10.1074/jbc.272.18.12116 Zervos, 1995, Mxi2, a mitogen-activated protein kinase that recognizes and phosphorylates Max protein, Proc. Natl. Acad. Sci. U. S. A., 92, 10531, 10.1073/pnas.92.23.10531 Zhang, 1995, Rho family GTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1, J. Biol. Chem., 270, 23934, 10.1074/jbc.270.41.23934 Zhao, 1999, Regulation of the MEF2 family of transcription factors by p38, Mol. Cell Biol., 19, 21, 10.1128/MCB.19.1.21 Zu, 1997, High expression and activation of MAP kinase-activated protein kinase 2 in cardiac muscle cells, J. Mol. Cell. Cardiol., 29, 2159, 10.1006/jmcc.1997.0449 Zu, 1998, p38 mitogen-activated protein kinase activation is required for human neutrophil function triggered by TNF-α or FMLP stimulation, J. Immunol., 160, 1982, 10.4049/jimmunol.160.4.1982